Hypercoagulable States and the Toxic Oil Syndrome
Authors: M. CASTRO GARCÍA
Journal: Annals of Internal Medicine (1986)

Letters and Corrections1 May 1986Hypercoagulable States and the Toxic Oil SyndromeM. CASTRO GARCÍA, M.D., M. POSADA, M.D., F. DIAZ DE ROJAS, M.D., I. ABAITUA BORDA, M.D., J. M. TABUENCA OLIVER, M.D.M. CASTRO GARCÍA, M.D.Search for more papers by this author, M. POSADA, M.D.Search for more papers by this author, F. DIAZ DE ROJAS, M.D.Search for more papers by this author, I. ABAITUA BORDA, M.D.Search for more papers by this author, J. M. TABUENCA OLIVER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-104-5-730_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: In his exhaustive review of the hypercoagulable states (1), Schafer makes no mention of the situation caused by those diseases having increased eosinophil counts, the most evident of which might be the hypereosinophilic syndrome. Regarding this entity, there have been reports of arterial intimal lesions, which might explain the trend to thromboembolic phenomena (2), but there also are procoagulating substances released by both the macrophages (3) and eosinophils (2) in these patients.We in Spain have had the opportunity to observe a new clinical entity, the toxic oil syndrome (4), with its symptoms of eosinophilia, endothelial damage,...References1. SCHAFER A. The hypercoagulable states. Ann Intern Med. 1985;102:814-28. LinkGoogle Scholar2. HARLEY J. Clinical manifestations of patients with hypereosinophilic syndrome, pp 82-4. In: FAUCI AS, moderator. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med. 1982;97:78-92. MedlineGoogle Scholar3. PASERINIDONATISEMERAROCOFRANCESCOCORTELLARO CMNEM. Monocyte procoagulant activity in hypereosinophilic syndrome. Lancet. 1983;2:460-1. CrossrefGoogle Scholar4. TABUENCA OLIVER J. Toxic allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet. 1981;2:567-8. CrossrefMedlineGoogle Scholar5. RIBERACALEROMARTINMARTIN NUÑEZMONTEAGUDOMONTEJO CTAGDJ. Patologia hematologica en el S. T.E. In: Symposium National Síndrome TÓXICO. Madrid: Ministerio de Sanidad y Consumo; 1982:346-51. Google Scholar6. FERNANDEZ PAVONGARCIA MUÑOZCUESTA GARCIALOPEZ PASTOR AMVA. Valoración de la hemostasia en pacientes afectos del síndrome Tóxico. In: Symposium National Sìndrome Tóxico. Madrid: Ministerio de Sanidad y Consumo; 1982;368-70. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Santa Engracia; 28010 Madrid Spain PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByEl síndrome del aceite tóxico: 30 años despuésHallazgos clínicos y analíticos en pacientes afectados por el síndrome del aceite tóxico. Estudio de una cohorte de 758 pacientesToxicologists versus Toxicological Disasters: Toxic Oil Syndrome, Clinical AspectsFatty acid conjugates of xenobioticsSynergistic vascular toxicity and fatty acid anilides in the toxic oil syndromeToxicity of oleic acid anilide in ratsToxic oil syndrome: A current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndromeParticipation of eosinophils in the toxic oil syndrome 1 May 1986Volume 104, Issue 5Page: 730-730KeywordsEosinophiliaEosinophilsLesionsOils Issue Published: 1 May 1986 PDF DownloadLoading ...